Fig. 3From: Combining epigenetic and clinicopathological variables improves specificity in prognostic prediction in clear cell renal cell carcinomaCumulative incidence of progress (pCIP5y). Seventy-eight non-metastatic tumors were classified using a the Mayo Scoring System (Mayo) and b the triple classifier (clinical + PI-CpGs + DCA) at diagnosis. The pCIP5y were compared in the risk groups. Log-rank p-values are presentedBack to article page